A population based case-control teratologic study of oral metronidazole treatment during pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 3, 1998, Pages 322-327

  Czeizel, Andrew E ^a   Rockenbauer, Magda ^a  

^a National Institute of Hygiene Budapest   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE CONTROL STUDY; CLEFT LIP; CLEFT LIP PALATE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL;

ABNORMALITIES, DRUG-INDUCED; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ANIMALS; ANTITRICHOMONAL AGENTS; CASE-CONTROL STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; HUNGARY; MEDICAL RECORDS; METRONIDAZOLE; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TRICHOMONAS INFECTIONS; TRICHOMONAS VAGINALIS;

EID: 0031938752     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10094.x     Document Type: Article

References (18)

1. Czeizel AE. Primary prevention of birth defects by periconceptional care, including multivitamin supplementation. Bailleres Clin Obstet Gynaecol 1995; 9: 417–430.
2. Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: A meta-analysis. Am J Obstet Gynecol 1995; 172: 525–529.
3. Czeizel AE. Analysis of medical indications for induced abortions in Hungary [in Hungarian with English abstract]. Orvosi Hetilap 1983; 124: 1297–1302.
4. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997; 55: 299–305.
5. Czeizel AE, Rácz J. Evaluation of drug intake during pregnancy in the Hungarian Case-Control Surveillance of Congenital Anomalies. Teratology 1990; 505–512.
6. Heisterberg L. Placental transfer of metronidazole in the first trimester of pregnancy. J Perinat Med 1984; 12: 43–45.
7. Roe JFC. A critical appraisal of the toxicology of metronidazole. In: Phillips I, Collier J, editors. Metronidazole. New York : Academic Press, 1979: 215–222.
8. Scott-Gray M. Metronidazole in obstetric practice. Obstet Gynecol 1965; 93: 502–505.
9. Robinson SC, Mirchandani G. Trichoinonas vaginalis. V. Further observations on metronidazole (including infant follow-up). Am J Obstet Gynecol 1965; 93: 502–505.
10. Rodin P, Hass G. Metronidazole in pregnancy. Br J Vener Dis 1966; 42: 210–212.
11. Peterson W, Stauch J, Ryder C. Metronidazole in pregnancy. Am J Obstet Gynecol 1966; 94: 343–349.
12. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, Massachusetts : PSG Publishing, 1977: 296–302.
13. Morgan IFK. Metronidazole treatment in pregnancy. In: Phillips I, Collier J, editors. Metronidazole. New York : Academic Press, 1979: 245–247.
14. Rosa FW, Baum C, Shaw M. Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet Gynecol 1987; 69: 751–755.
15. Cantu JM, Garcia-Cruz D. Midline facial defect as a teratogenic effect of metronidazole. Birth Defects 1982; 18: 85–88.
16. Greenberg F. Metronidazole and pregnancy. Am J Med Genet 1985; 22: 825.
17. Czeizel AE, Tusnády G. An epidemiologic study of cleft lip with or without cleft palate and posterior cleft palate in Hungary. Hum Hered 1971; 21: 17–38.
18. Czeizel AE, Intõdy Zs, Modell B. What proportion of congenital abnormalities can be prevented BMJ 1993; 306: 499–503.